Evolus, Inc. (EOLS) stock
EOLSNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.69+0.06 (+0.90%)
Close on Nov 17, 2026Market cap $441.88MP/E –Yield –
Evolus price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Evolus's price to book ratio was 131.1× on Apr 30, 2025, against 82.0× a year earlier. Over the last 5 years it ranged from 1.8× to 167.8×, with a median of 10.8×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Apr 30, 2025 | 131.1× | +12.5 |
| 2024 | Dec 31, 2024 | 118.6× | +36.5 |
| 2023 | Jul 31, 2023 | 82.0× | +67.6 |
| 2022 | Dec 30, 2022 | 14.4× | +10.7 |
| 2021 | Dec 31, 2021 | 3.7× | +0.5 |
| 2020 | Dec 31, 2020 | 3.2× | −16.4 |
| 2019 | Dec 31, 2019 | 19.6× | +16.2 |
| 2018 | Dec 31, 2018 | 3.4× | – |
See a number that looks wrong?